Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Opus Genetics (IRD) Non Operating Income (2020 - 2026)

Opus Genetics has reported Non Operating Income over the past 12 years, most recently at $844000.0 for Q1 2026.

  • Quarterly Non Operating Income rose 179.47% to $844000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $2.5 million through Mar 2026, down 39.3% year-over-year, with the annual reading at $2.0 million for FY2025, 55.5% down from the prior year.
  • Non Operating Income was $844000.0 for Q1 2026 at Opus Genetics, up from $703000.0 in the prior quarter.
  • Over five years, Non Operating Income peaked at $2.8 million in Q4 2024 and troughed at -$82000.0 in Q1 2022.
  • The 5-year median for Non Operating Income is $456000.0 (2023), against an average of $536823.5.
  • Year-over-year, Non Operating Income crashed 8300.0% in 2022 and then soared 6414.29% in 2023.
  • A 5-year view of Non Operating Income shows it stood at $46000.0 in 2022, then surged by 1232.61% to $613000.0 in 2023, then surged by 360.36% to $2.8 million in 2024, then plummeted by 75.09% to $703000.0 in 2025, then rose by 20.06% to $844000.0 in 2026.
  • Per Business Quant, the three most recent readings for IRD's Non Operating Income are $844000.0 (Q1 2026), $703000.0 (Q4 2025), and $450000.0 (Q3 2025).